Free Trial
NASDAQ:PIII

P3 Health Partners (PIII) Stock Price, News & Analysis

P3 Health Partners logo
$6.61 -0.03 (-0.45%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$6.60 -0.02 (-0.23%)
As of 07/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About P3 Health Partners Stock (NASDAQ:PIII)

Key Stats

Today's Range
$6.30
$7.50
50-Day Range
$6.03
$8.45
52-Week Range
$6.00
$32.54
Volume
8,504 shs
Average Volume
19,885 shs
Market Capitalization
$47.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.25
Consensus Rating
Moderate Buy

Company Overview

P3 Health Partners Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

PIII MarketRank™: 

P3 Health Partners scored higher than 62% of companies evaluated by MarketBeat, and ranked 372nd out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    P3 Health Partners has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    P3 Health Partners has only been the subject of 1 research reports in the past 90 days.

  • Read more about P3 Health Partners' stock forecast and price target.
  • Earnings Growth

    Earnings for P3 Health Partners are expected to grow in the coming year, from ($0.67) to ($0.37) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of P3 Health Partners is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of P3 Health Partners is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    P3 Health Partners has a P/B Ratio of 0.62. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about P3 Health Partners' valuation and earnings.
  • Percentage of Shares Shorted

    1.70% of the float of P3 Health Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    P3 Health Partners has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in P3 Health Partners has recently decreased by 16.35%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    P3 Health Partners does not currently pay a dividend.

  • Dividend Growth

    P3 Health Partners does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.70% of the float of P3 Health Partners has been sold short.
  • Short Interest Ratio / Days to Cover

    P3 Health Partners has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in P3 Health Partners has recently decreased by 16.35%, indicating that investor sentiment is improving significantly.
    • Insider Buying vs. Insider Selling

      In the past three months, P3 Health Partners insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      17.79% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      Only 7.75% of the stock of P3 Health Partners is held by institutions.

    • Read more about P3 Health Partners' insider trading history.
    Receive PIII Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter.

    PIII Stock News Headlines

    P3 Health Partners Inc. (PIII) - Yahoo Finance
    I was wrong about Trump
    I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
    See More Headlines

    PIII Stock Analysis - Frequently Asked Questions

    P3 Health Partners' stock was trading at $11.2450 on January 1st, 2025. Since then, PIII stock has decreased by 41.2% and is now trading at $6.61.

    P3 Health Partners Inc. (NASDAQ:PIII) released its quarterly earnings data on Thursday, May, 15th. The company reported ($6.28) EPS for the quarter, missing analysts' consensus estimates of ($5.00) by $1.28. The firm had revenue of $373.23 million for the quarter, compared to analysts' expectations of $362.09 million. P3 Health Partners had a negative net margin of 9.27% and a negative trailing twelve-month return on equity of 123.10%.
    Read the conference call transcript
    .

    P3 Health Partners shares reverse split before market open on Monday, April 14th 2025.The 1-50 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, April 11th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

    P3 Health Partners' top institutional investors include Trinity Financial Advisors LLC (0.35%). Insiders that own company stock include Pacific Founders Ugp Chicago, Pacific Founders Ugp I Chicago, Sherif Abdou and Atul Kavthekar.
    View institutional ownership trends
    .

    Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

    Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include Avino Silver & Gold Mines (ASM), PayPal (PYPL), TriNet Group (TNET), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV), 3M (MMM) and nCino (NCNO).

    Company Calendar

    Last Earnings
    5/15/2025
    Today
    7/19/2025
    Next Earnings (Estimated)
    8/06/2025
    Fiscal Year End
    12/31/2025

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MEDICAL INFO SYS
    Sub-Industry
    Healthcare
    Current Symbol
    NASDAQ:PIII
    CIK
    1832511
    Fax
    N/A
    Employees
    500
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $20.00
    Low Price Target
    $12.50
    Potential Upside/Downside
    +145.8%
    Consensus Rating
    Moderate Buy
    Rating Score (0-4)
    2.50
    Research Coverage
    2 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($47.28)
    Trailing P/E Ratio
    N/A
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    -$135.85 million
    Net Margins
    -9.27%
    Pretax Margin
    -20.31%
    Return on Equity
    -123.10%
    Return on Assets
    -15.94%

    Debt

    Debt-to-Equity Ratio
    1.68
    Current Ratio
    0.38
    Quick Ratio
    0.38

    Sales & Book Value

    Annual Sales
    $1.50 billion
    Price / Sales
    0.03
    Cash Flow
    N/A
    Price / Cash Flow
    N/A
    Book Value
    $10.58 per share
    Price / Book
    0.62

    Miscellaneous

    Outstanding Shares
    7,190,000
    Free Float
    5,909,000
    Market Cap
    $47.53 million
    Optionable
    Not Optionable
    Beta
    0.78
    7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

    Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

    Get This Free Report

    This page (NASDAQ:PIII) was last updated on 7/19/2025 by MarketBeat.com Staff
    From Our Partners